is retatrutide a glp 1 drug vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide vs Tirzepatide (2026): Differences

Abstract Inflammatory bowel diseases (IBD), including Crohns disease (CD) and ulcerative colitis (UC), are chronic, relapsing, intestinal inflammatory disorders with complex and yet unrevealed pathogenesis in which genetic, immunological, and environmental factors play a role

An actual system

Adverse drug reaction from drinking alcohol while on phentermine

Framing it as the next step after semaglutide or tirzepatide dramatically understates its strategic significance

doi: 10.2337/db14-1706

The difference is that retatrutide adds glucagon receptor activity to GIP and GLP-1 activity, which is why the obesity research community is watching its long-term data closely